Phoreus Biotechnology, Inc. — Form D/A

Phoreus Biotechnology, Inc. of OLATHE, KS, a company, filed a Form D amendment with the SEC on 2026-03-13. $4.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Douglas` ShaneDirectorLouisburg, KS
Douglas` ShanePromoterLouisburg, KS
Bill AshleyRelated PersonOverland Park, KS
Scott NagleyRelated PersonDenver, CO
Rajeet PannuRelated PersonNew York, NY
David SchaeferRelated PersonClearwater Beach, FL
Steve SchramRelated PersonGoodyear, AZ
Douglas` ShaneRelated PersonLouisburg, KS
Matthew TomichRelated PersonSeattle, WA
Christopher BrandtDirectorBaltimore, MD
Michael CoeDirectorPerry, KS
Michael CoeExecutive OfficerPerry, KS
Lynn RundleDirectorAbingdon, VA
Bradley HollidayDirectorKansas City, MO
Nathan SinghDirectorSaint Louis, MO
Matthew TomichDirectorSeattle, WA
Matthew TomichPromoterSeattle, WA
Randall ToshDirectorOlathe, KS
Randall ToshExecutive OfficerOlathe, KS
Rajeet PannuDirectorNew York, NY
Rajeet PannuPromoterNew York, NY
Xiomara Sinisterra-HunterDirectorPort Saint Lucie, FL
David SchaeferDirectorClearwater Beach, FL
David SchaeferExecutive OfficerClearwater Beach, FL
David SchaeferPromoterClearwater Beach, FL

Other filings by this issuer (6)

FiledFormOfferingSold
2026-03-13D$421K
2022-05-11D/A$3.0M$1.9M
2020-05-26D$2.0M
2019-12-30D/A$1.1M$550K
2019-07-19D/A$1.1M$300K
2018-08-02D$1.0M$50K

More